MKI67 and neoplasm: JPX‐0750 treatment induced a significant reduction in Ki67+ cells in the Myla‐derived tumors (P‐value: < 0.0001) alongside a trend toward tumor perimeter/weight reduction (perimeter P‐value: 0.0622, weight P‐value: 0.5805; Fig 7C, E and G).